Clinical studies recruiting near Anyang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · Anyang Cancer Hospital · Fudan University · NCT06521866 Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Hallym University Sacred Heart Hospital · Walden Biosciences · NCT06466135 Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 · Department 4th of Radiation Oncology, Anyang Cancer Hospital · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821778 A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, S
Phase 1 · Metro Hospital · Korea United Pharm. Inc. · NCT07682948 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · AnYang Tumor Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · The People's Hospital Of Anyang City · Kunming Pharmaceuticals, Inc. · NCT07279493 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Brea
Phase 2/Phase 3 · AnYang Tumor Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05744687 The DECISION-CTO Extended 10 Y Follow-up
Phase N/A · SAM hospital · Seung-Jung Park · NCT06908499 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Anyang Cancer Hospital · Eli Lilly and Company · NCT06890598 IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer
Phase 1/Phase 2 · Anyang Cancer Hospital · InxMed (Shanghai) Co., Ltd. · NCT05551507 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · Nanyang Second General Hospital · RemeGen Co., Ltd. · NCT07105215 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · Anyang Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · Hallym University Sacred Heart Hospital · Regeneron Pharmaceuticals · NCT06975787 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · Anyang Tumor Hospital · Antengene Biologics Limited · NCT07327229 Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post
Phase 3 · Anyang People's Hospital · Capital Medical University · NCT07509645 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · Research Site · AstraZeneca · NCT06535607 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Anyang Cancer Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · Hua county People's Hospital · Capital Medical University · NCT06548971 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Phase N/A · Hallym University Sacred Heart Hospital · Seung-Jung Park · NCT01366404 A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER
Phase 2/Phase 3 · Anyang Cancer Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06891833 Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Phase 3 · Puyang Anyang District Hospital · Beijing Tiantan Hospital · NCT06157502 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Phase 2 · Anyang Cancer Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05872347 A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esopha
Phase 3 · 102 · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07487896 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Phase 1/Phase 2 · Anyang Cancer Hospital · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06214143 Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer
Phase 2 · Anyang Cancer Hospital · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06421376 A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · Research Site · AstraZeneca · NCT07222917 A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chro
Phase 4 · Investigational Site Number : 4100005 · Sanofi · NCT07053423 Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gast
Phase 4 · Hallym University Sacred Heart Hospital · Duk-Woo Park, MD · NCT04416581 A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older Wi
Phase 2 · Research Site · AstraZeneca · NCT07088926

Look up another city

Look up another condition